文献速递生殖医学母胎医学

冻胚与新鲜胚胎移植后辅助生殖技术出生的8至9岁单胎儿童的心血管功能

Cardiovascular function in 8- to 9-year-old singletons born after ART with frozen and fresh embryo transfer.
PubMed 文献 · Hum Reprod · 2022-01-01

该队列研究纳入冻胚移植、新鲜胚胎移植及自然受孕的8至9岁单胎儿童各50例,于2018年11月至2020年8月通过心脏磁共振及无创血压评估动脉僵硬度。结果显示三组主动脉升段扩张性无显著差异,包括动脉僵硬度在内的心血管功能未见改变。

要点

  • 冻胚移植、新鲜胚胎移植与自然受孕儿童的主动脉升段扩张性无显著差异。
  • 校正混杂因素后,冻胚移植组主动脉升段扩张性较新鲜胚胎移植组和自然受孕组呈非显著降低趋势。
  • 次要及探索性结局在各组间无差异,主要和次要结局的组内评分者信度良好。

核心结论

  • 冻胚移植或新鲜胚胎移植出生的8至9岁单胎儿童与自然受孕儿童相比,包括动脉僵硬度在内的心血管功能未见改变。

研究设计与样本

  • 队列研究,纳入冻胚移植、新鲜胚胎移植及自然受孕的8至9岁单胎儿童各50例,共150例,于2018年11月至2020年8月开展。
  • 通过丹麦体外受精登记处和医学出生登记处识别受试者,进行心脏磁共振成像和人体测量,父母数据通过问卷收集。
  • 自然受孕儿童按性别和出生年份与冻胚移植/新鲜胚胎移植儿童匹配,排除先天性心脏病、母亲妊娠期糖尿病或母亲糖尿病。

主要发现

  • 主动脉升段扩张性(均值(标准差)):冻胚移植组11.1(3.6)10-3 mmHg-1,新鲜胚胎移植组11.8(3.0)10-3 mmHg-1,自然受孕组11.4(2.8)10-3 mmHg-1,P > 0.05。
  • 多变量线性回归校正儿童性别和年龄、母亲早孕期BMI及母亲教育水平后,各组与主动脉升段扩张性无统计学显著差异。
  • 完全校正模型显示,冻胚移植组较新鲜胚胎移植组主动脉升段扩张性呈非显著降低趋势(β估计值(95%CI):-0.99 10-3 mmHg-1(-2.20; 0.21))。
  • 完全校正模型显示,冻胚移植组较自然受孕组主动脉升段扩张性呈非显著降低趋势(β估计值(95%CI):-0.77 10-3 mmHg-1(-1.98; 0.44))。
  • 次要及探索性结局在各组间无差异,主要和次要结局的组内评分者信度良好。

临床怎么用

  • 作者认为,冻胚移植或新鲜胚胎移植出生的儿童心血管功能未改变,这对未来辅助生殖技术的使用是令人安心的。

局限性

  • 可能存在选择偏倚,因为辅助生殖技术组的参与率高于自然受孕组。
  • 在一些变量上,研究组与未参与人群略有差异;未参与人群(n = 1770)包括被排除者、未被邀请进行心脏磁共振扫描者或拒绝参与本研究。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

STUDY QUESTION: Do 8- to 9-year-old singletons conceived after frozen embryo transfer (FET) or fresh embryo transfer (Fresh-ET) have increased arterial stiffness compared to naturally conceived (NC) children? SUMMARY ANSWER: The process of FET or Fresh-ET is not associated with altered cardiovascular function in 8- to 9-year-old singletons, including arterial stiffness, as compared to NC children. WHAT IS KNOWN ALREADY: ART has been suggested to influence cardiovascular risk factors (i.e. endothelial dysfunction, increased arterial blood pressure and insulin resistance). It is not known if ART procedures alter arterial stiffness in singletons. STUDY DESIGN, SIZE, DURATION: A cohort study was carried out, including 8- to 9-year-old singletons conceived after FET, Fresh-ET and NC children (50 children in each group). This study was conducted between November 2018 and August 2020. PARTICIPANTS/MATERIALS, SETTING, METHODS: In total, 150 singletons were identified through the Danish IVF Registry and the Medical Birth Registry. They underwent cardiac magnetic resonance imaging (CMR) and anthropometric measurements. Parental data were collected using questionnaires. NC children were matched by sex and birth year with FET/Fresh-ET children. Exclusion criteria were congenital heart disease, maternal gestational diabetes or maternal diabetes mellitus. Our primary outcome was arterial stiffness, which is assessed from noninvasive arterial blood pressure and aortic ascendens distensibility. The secondary outcome was the pulse wave velocity of total aorta and exploratory outcomes were left ventricular ejection fraction, mean arterial pressure, cardiac output and total peripheral resistance. Measurements and analyses were performed blinded to the child group. MAIN RESULTS AND THE ROLE OF CHANCE: Aortic ascendens distensibility of children conceived after FET and Fresh-ET did not differ from NC children (mean (SD): FET 11.1 (3.6) 10-3 mmHg-1, Fresh-ET 11.8 (3.0) 10-3 mmHg-1, NC 11.4 (2.8) 10-3 mmHg-1, P > 0.05). Multivariate linear regression was performed to adjust for potential confounders (i.e. child sex and age, maternal BMI at early pregnancy and maternal educational level). Data showed no statistically significant differences between study groups and aortic ascendens distensibility. However, the fully adjusted model showed a non-significant tendency of lowered aortic ascendens distensibility in children born after FET compared to Fresh-ET (β estimate (95% CI): -0.99 10-3 mmHg-1 (-2.20; 0.21)) and NC children (β estimate (95% CI): -0.77 10-3 mmHg-1 (-1.98; 0.44)). Lastly, secondary and exploratory outcomes did not differ between the groups. Primary and secondary outcomes showed good intra-rater reliability. LIMITATIONS, REASONS FOR CAUTION: This study is possibly limited by potential selection bias as the participation rate was higher in the ART compared to the NC group. Also, in some variables, the study groups differed slightly from the non-participant population. The non-participant population (n = 1770) included those who were excluded, not invited to CMR scan, or declined to participate in this study. WIDER IMPLICATIONS OF THE FINDINGS: Our findings indicate that children born after FET or Fresh-ET do not have altered cardiovascular function, including arterial stiffness. This is reassuring for the future use of ART. STUDY FUNDING/COMPETING INTEREST(S): This study was funded by the Novo Nordisk Foundation (grant reference number: NNF19OC0054340) and The Research Foundation of Rigshospitalet. All authors declared no conflict of interests. TRIAL REGISTRATION NUMBER: ClinicalTrials.gov identifier: NCT03719703.

来源:Hum Reprod,查看原文。版权归原作者所有。

引用

  1. Mizrak I, Asserhøj LL, Lund MAV, et al. Cardiovascular function in 8- to 9-year-old singletons born after ART with frozen and fresh embryo transfer. Hum Reprod. 2022. PMID: 35015837. doi:10.1093/humrep/deab284

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。